 | • レポートコード：MRC2012B1198 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Service & Software |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、パーソナライズ抗がん剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。パーソナライズ抗がん剤の種類別市場規模（免疫療法、標的療法、化学療法、ホルモン療法、その他）、用途別市場規模（乳がん、血液がん、胃腸がん、前立腺がん、皮膚がん、肺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Bristol-Myers Squibb、Sanofi、GlaxoSmithKline、Merck、Novartis、Ariad Pharmaceuticals、Amgen、Pfizer、Celgene Corporation、Teva Pharmaceuticals、Eli Lilly、Johnson and Johnson、Hoffmann-La Roche、Boehringer Ingelheim、 ・地域別グローバル市場分析 2015年-2020年 ・パーソナライズ抗がん剤の北米市場（アメリカ、カナダ、メキシコ） ・パーソナライズ抗がん剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・パーソナライズ抗がん剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・パーソナライズ抗がん剤の南米市場（ブラジル、アルゼンチン） ・パーソナライズ抗がん剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫療法、標的療法、化学療法、ホルモン療法、その他 ・用途別分析：乳がん、血液がん、胃腸がん、前立腺がん、皮膚がん、肺がん、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Personalizing Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Personalizing Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Personalizing Cancer Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Personalizing Cancer Drugs market has been segmented into:
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
By Application, Personalizing Cancer Drugs has been segmented into:
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Personalizing Cancer Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Personalizing Cancer Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Personalizing Cancer Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Personalizing Cancer Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Personalizing Cancer Drugs Market Share Analysis
Personalizing Cancer Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Personalizing Cancer Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Personalizing Cancer Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Personalizing Cancer Drugs are:
Bayer
Bristol-Myers Squibb
Sanofi
GlaxoSmithKline
Merck
Novartis
Ariad Pharmaceuticals
Amgen
Pfizer
Celgene Corporation
Teva Pharmaceuticals
Eli Lilly
Johnson and Johnson
Hoffmann-La Roche
Boehringer Ingelheim
Table of Contents
1 Personalizing Cancer Drugs Market Overview
1.1 Product Overview and Scope of Personalizing Cancer Drugs
1.2 Classification of Personalizing Cancer Drugs by Type
1.2.1 Global Personalizing Cancer Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Personalizing Cancer Drugs Revenue Market Share by Type in 2019
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Chemotherapy
1.2.6 Hormone Therapy
1.2.7 Others
1.3 Global Personalizing Cancer Drugs Market by Application
1.3.1 Overview: Global Personalizing Cancer Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Blood Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Skin Cancer
1.3.7 Lung Cancer
1.3.8 Others
1.4 Global Personalizing Cancer Drugs Market by Regions
1.4.1 Global Personalizing Cancer Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Personalizing Cancer Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Personalizing Cancer Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Personalizing Cancer Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Personalizing Cancer Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Personalizing Cancer Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Personalizing Cancer Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ariad Pharmaceuticals
2.7.1 Ariad Pharmaceuticals Details
2.7.2 Ariad Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ariad Pharmaceuticals SWOT Analysis
2.7.4 Ariad Pharmaceuticals Product and Services
2.7.5 Ariad Pharmaceuticals Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Celgene Corporation
2.10.1 Celgene Corporation Details
2.10.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Celgene Corporation SWOT Analysis
2.10.4 Celgene Corporation Product and Services
2.10.5 Celgene Corporation Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceuticals
2.11.1 Teva Pharmaceuticals Details
2.11.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceuticals SWOT Analysis
2.11.4 Teva Pharmaceuticals Product and Services
2.11.5 Teva Pharmaceuticals Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eli Lilly SWOT Analysis
2.12.4 Eli Lilly Product and Services
2.12.5 Eli Lilly Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Johnson and Johnson
2.13.1 Johnson and Johnson Details
2.13.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Johnson and Johnson SWOT Analysis
2.13.4 Johnson and Johnson Product and Services
2.13.5 Johnson and Johnson Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hoffmann-La Roche
2.14.1 Hoffmann-La Roche Details
2.14.2 Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hoffmann-La Roche SWOT Analysis
2.14.4 Hoffmann-La Roche Product and Services
2.14.5 Hoffmann-La Roche Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Boehringer Ingelheim
2.15.1 Boehringer Ingelheim Details
2.15.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Boehringer Ingelheim SWOT Analysis
2.15.4 Boehringer Ingelheim Product and Services
2.15.5 Boehringer Ingelheim Personalizing Cancer Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Personalizing Cancer Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Personalizing Cancer Drugs Players Market Share
3.2.2 Top 10 Personalizing Cancer Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Personalizing Cancer Drugs Revenue and Market Share by Regions
4.2 North America Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
5 North America Personalizing Cancer Drugs Revenue by Countries
5.1 North America Personalizing Cancer Drugs Revenue by Countries (2015-2020)
5.2 USA Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
6 Europe Personalizing Cancer Drugs Revenue by Countries
6.1 Europe Personalizing Cancer Drugs Revenue by Countries (2015-2020)
6.2 Germany Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
6.4 France Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Personalizing Cancer Drugs Revenue by Countries
7.1 Asia-Pacific Personalizing Cancer Drugs Revenue by Countries (2015-2020)
7.2 China Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
7.5 India Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
8 South America Personalizing Cancer Drugs Revenue by Countries
8.1 South America Personalizing Cancer Drugs Revenue by Countries (2015-2020)
8.2 Brazil Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Personalizing Cancer Drugs by Countries
9.1 Middle East & Africa Personalizing Cancer Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Personalizing Cancer Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Personalizing Cancer Drugs Market Forecast by Type (2019-2024)
10.3 Immunotherapy Revenue Growth Rate (2015-2025)
10.4 Targeted Therapy Revenue Growth Rate (2015-2025)
10.5 Chemotherapy Revenue Growth Rate (2015-2025)
10.6 Hormone Therapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Personalizing Cancer Drugs Market Segment by Application
11.1 Global Personalizing Cancer Drugs Revenue Market Share by Application (2015-2020)
11.2 Personalizing Cancer Drugs Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2015-2020)
11.4 Blood Cancer Revenue Growth (2015-2020)
11.5 Gastrointestinal Cancer Revenue Growth (2015-2020)
11.6 Prostate Cancer Revenue Growth (2015-2020)
11.7 Skin Cancer Revenue Growth (2015-2020)
11.8 Lung Cancer Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global Personalizing Cancer Drugs Market Size Forecast (2021-2025)
12.1 Global Personalizing Cancer Drugs Market Size Forecast (2021-2025)
12.2 Global Personalizing Cancer Drugs Market Forecast by Regions (2021-2025)
12.3 North America Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
12.6 South America Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Personalizing Cancer Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Personalizing Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Personalizing Cancer Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Personalizing Cancer Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bayer Corporate Information, Location and Competitors
Table 6. Bayer Personalizing Cancer Drugs Major Business
Table 7. Bayer Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Bayer SWOT Analysis
Table 9. Bayer Personalizing Cancer Drugs Product and Solutions
Table 10. Bayer Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 12. Bristol-Myers Squibb Personalizing Cancer Drugs Major Business
Table 13. Bristol-Myers Squibb Personalizing Cancer Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Bristol-Myers Squibb SWOT Analysis
Table 15. Bristol-Myers Squibb Personalizing Cancer Drugs Product and Solutions
Table 16. Bristol-Myers Squibb Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Personalizing Cancer Drugs Major Business
Table 19. Sanofi Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Personalizing Cancer Drugs Product and Solutions
Table 22. Sanofi Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GlaxoSmithKline Corporate Information, Location and Competitors
Table 24. GlaxoSmithKline Personalizing Cancer Drugs Major Business
Table 25. GlaxoSmithKline Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 26. GlaxoSmithKline SWOT Analysis
Table 27. GlaxoSmithKline Personalizing Cancer Drugs Product and Solutions
Table 28. GlaxoSmithKline Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Personalizing Cancer Drugs Major Business
Table 31. Merck Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Personalizing Cancer Drugs Product and Solutions
Table 34. Merck Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Personalizing Cancer Drugs Major Business
Table 37. Novartis Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Personalizing Cancer Drugs Product and Solutions
Table 40. Novartis Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Ariad Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Ariad Pharmaceuticals Personalizing Cancer Drugs Major Business
Table 43. Ariad Pharmaceuticals Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Ariad Pharmaceuticals SWOT Analysis
Table 45. Ariad Pharmaceuticals Personalizing Cancer Drugs Product and Solutions
Table 46. Ariad Pharmaceuticals Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Amgen Corporate Information, Location and Competitors
Table 48. Amgen Personalizing Cancer Drugs Major Business
Table 49. Amgen Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Amgen SWOT Analysis
Table 51. Amgen Personalizing Cancer Drugs Product and Solutions
Table 52. Amgen Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer Corporate Information, Location and Competitors
Table 54. Pfizer Personalizing Cancer Drugs Major Business
Table 55. Pfizer Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer SWOT Analysis
Table 57. Pfizer Personalizing Cancer Drugs Product and Solutions
Table 58. Pfizer Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Celgene Corporation Corporate Information, Location and Competitors
Table 60. Celgene Corporation Personalizing Cancer Drugs Major Business
Table 61. Celgene Corporation Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Celgene Corporation SWOT Analysis
Table 63. Celgene Corporation Personalizing Cancer Drugs Product and Solutions
Table 64. Celgene Corporation Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Teva Pharmaceuticals Corporate Information, Location and Competitors
Table 66. Teva Pharmaceuticals Personalizing Cancer Drugs Major Business
Table 67. Teva Pharmaceuticals Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Teva Pharmaceuticals SWOT Analysis
Table 69. Teva Pharmaceuticals Personalizing Cancer Drugs Product and Solutions
Table 70. Teva Pharmaceuticals Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Eli Lilly Corporate Information, Location and Competitors
Table 72. Eli Lilly Personalizing Cancer Drugs Major Business
Table 73. Eli Lilly Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 74. Eli Lilly SWOT Analysis
Table 75. Eli Lilly Personalizing Cancer Drugs Product and Solutions
Table 76. Eli Lilly Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Johnson and Johnson Corporate Information, Location and Competitors
Table 78. Johnson and Johnson Personalizing Cancer Drugs Major Business
Table 79. Johnson and Johnson Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 80. Johnson and Johnson SWOT Analysis
Table 81. Johnson and Johnson Personalizing Cancer Drugs Product and Solutions
Table 82. Johnson and Johnson Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 84. Hoffmann-La Roche Personalizing Cancer Drugs Major Business
Table 85. Hoffmann-La Roche Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 86. Hoffmann-La Roche SWOT Analysis
Table 87. Hoffmann-La Roche Personalizing Cancer Drugs Product and Solutions
Table 88. Hoffmann-La Roche Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 90. Boehringer Ingelheim Personalizing Cancer Drugs Major Business
Table 91. Boehringer Ingelheim Personalizing Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 92. Boehringer Ingelheim SWOT Analysis
Table 93. Boehringer Ingelheim Personalizing Cancer Drugs Product and Solutions
Table 94. Boehringer Ingelheim Personalizing Cancer Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Personalizing Cancer Drugs Revenue (Million USD) by Players (2015-2020)
Table 96. Global Personalizing Cancer Drugs Revenue Share by Players (2015-2020)
Table 97. Global Personalizing Cancer Drugs Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Personalizing Cancer Drugs Revenue Market Share by Regions (2015-2020)
Table 99. North America Personalizing Cancer Drugs Revenue by Countries (2015-2020)
Table 100. North America Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 101. Europe Personalizing Cancer Drugs Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Personalizing Cancer Drugs Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Personalizing Cancer Drugs Revenue by Countries (2015-2020)
Table 104. South America Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Personalizing Cancer Drugs Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 107. Global Personalizing Cancer Drugs Revenue (Million USD) by Type (2015-2020)
Table 108. Global Personalizing Cancer Drugs Revenue Share by Type (2015-2020)
Table 109. Global Personalizing Cancer Drugs Revenue Forecast by Type (2021-2025)
Table 110. Global Personalizing Cancer Drugs Revenue by Application (2015-2020)
Table 111. Global Personalizing Cancer Drugs Revenue Share by Application (2015-2020)
Table 112. Global Personalizing Cancer Drugs Revenue Forecast by Application (2021-2025)
Table 113. Global Personalizing Cancer Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Personalizing Cancer Drugs Picture
Figure 2. Global Personalizing Cancer Drugs Revenue Market Share by Type in 2019
Figure 3. Immunotherapy Picture
Figure 4. Targeted Therapy Picture
Figure 5. Chemotherapy Picture
Figure 6. Hormone Therapy Picture
Figure 7. Others Picture
Figure 8. Personalizing Cancer Drugs Revenue Market Share by Application in 2019
Figure 9. Breast Cancer Picture
Figure 10. Blood Cancer Picture
Figure 11. Gastrointestinal Cancer Picture
Figure 12. Prostate Cancer Picture
Figure 13. Skin Cancer Picture
Figure 14. Lung Cancer Picture
Figure 15. Others Picture
Figure 16. Global Personalizing Cancer Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Personalizing Cancer Drugs Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Personalizing Cancer Drugs Revenue Market Share in 2019
Figure 25. Global Top 10 Players Personalizing Cancer Drugs Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Personalizing Cancer Drugs Revenue Market Share by Regions (2015-2020)
Figure 29. Global Personalizing Cancer Drugs Revenue Market Share by Regions in 2018
Figure 30. North America Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Europe Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 33. South America Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 35. North America Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. North America Personalizing Cancer Drugs Revenue Market Share by Countries in 2019
Figure 37. USA Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Canada Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Europe Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Personalizing Cancer Drugs Revenue Market Share by Countries in 2019
Figure 42. Germany Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 43. UK Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 44. France Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Russia Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Italy Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Personalizing Cancer Drugs Revenue Market Share by Countries in 2019
Figure 49. China Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Japan Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Korea Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 52. India Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 54. South America Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. South America Personalizing Cancer Drugs Revenue Market Share by Countries in 2019
Figure 56. Brazil Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Personalizing Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Personalizing Cancer Drugs Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 61. UAE Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Personalizing Cancer Drugs Revenue and Growth Rate (2015-2020)
Figure 64. Global Personalizing Cancer Drugs Revenue Share by Type (2015-2020)
Figure 65. Global Personalizing Cancer Drugs Revenue Share by Type in 2019
Figure 66. Global Personalizing Cancer Drugs Market Share Forecast by Type (2021-2025)
Figure 67. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 68. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 69. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 70. Global Hormone Therapy Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Personalizing Cancer Drugs Revenue Share by Application (2015-2020)
Figure 73. Global Personalizing Cancer Drugs Revenue Share by Application in 2019
Figure 74. Global Personalizing Cancer Drugs Market Share Forecast by Application (2021-2025)
Figure 75. Global Breast Cancer Revenue Growth Rate (2015-2020)
Figure 76. Global Blood Cancer Revenue Growth Rate (2015-2020)
Figure 77. Global Gastrointestinal Cancer Revenue Growth Rate (2015-2020)
Figure 78. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 79. Global Skin Cancer Revenue Growth Rate (2015-2020)
Figure 80. Global Lung Cancer Revenue Growth Rate (2015-2020)
Figure 81. Global Others Revenue Growth Rate (2015-2020)
Figure 82. Global Personalizing Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Personalizing Cancer Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Personalizing Cancer Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
Figure 86. Europe Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
Figure 88. South America Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Personalizing Cancer Drugs Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…- 腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…
- 腫瘍学/がん治療薬の世界市場（～2026年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastroint…
- 尿管がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ureter Cancer Drugs Market The global Ureter Cancer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ureter Cancer Drugs Scope and Market Size Ureter Cancer Drugs market is seg…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…